PyroGenesis Announces $3.0 Million Bought Deal LIFE Offering and Concurrent CEO Private Placement of up to $2.0 Million
PyroGenesis’s deep‑discount bought deal caps a year of cash‑burn, diluting holders just as operational wins appeared to turn the corner.
PyroGenesis announced a bought‑deal public offering with Research Capital Corporation for 8,825,000 units at $0.34 per unit for gross proceeds of $3.0 million, with an underwriter’s option for up to 15 % more. Each unit comprises one common share and one warrant exercisable at $0.42 for 36 months. Concurrently, CEO P. Peter Pascali will subscribe for up to $2.0 million in a non‑brokered private placement (warrant term 24 months, exercise price not disclosed). Total gross proceeds, including the underwriter’s option, could reach $5.45 million. Proceeds are earmarked for working capital and contract/backlog advances. The offering is priced at a 12.8 % discount to the last closing price of $0.39 and a deep discount to the $0.54 unit price of the private placement closed only two months ago.
The news is materially negative. While the company frames the raise as supporting a $43 million backlog, the structure – a bought deal at $0.34 with a warrant sweetener – signals that the company could not attract capital at a higher price. Shareholders face immediate dilution of roughly 10–15 % (depending on final shares issued) at a price well below recent trading levels. The CEO’s concurrent investment of $2 million provides some insider alignment, but it also follows a pattern of repeated dilutive financings: a $1.97 million placement at $0.54 in March 2026, a $5.2 million multi‑tranche raise at $0.20–$0.63 in late 2025, and earlier infusions. Despite strong operational progress (plasma torches validated by Rio Tinto/Alcoa/Constellium, titanium powder orders, graphite breakthrough, fumed silica pilot success), the company continues to consume cash and reports net losses. The Q1 2026 results showed a narrowed loss of $1.0 million but cash remains tight, and the need for another near‑term financing – at a sharply lower price – erodes confidence that the company can self‑fund its growth. The market reacted with the stock falling to $0.39 on the day, near multi‑week lows.
PyroGenesis designs, develops and commercializes advanced plasma‑based technologies for heavy industry. Its core verticals: aluminum & metals (electric plasma torches replacing fossil‑fuel burners in melting furnaces, validated with Rio Tinto, Alcoa, Constellium), materials production (NexGen™ plasma atomized titanium powder for additive manufacturing; plasma‑produced battery‑grade carbon black, graphite, and fumed silica), and waste & environmental solutions (SPARC™ refrigerant destruction, PACWADS chemical weapons neutralization, radioactive waste treatment, battery recycling). The flagship offers are the high‑power plasma torch systems for aluminum decarbonization and the titanium powder business, which is gaining commercial orders. The fumed silica reactor (with HPQ Silicon) is nearing commercialization, and the graphite‑from‑carbon‑black process carries royalties on future plants.